Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05975658 · ClinicalTrials.gov registry record
WIReD: Wireless Interstage Remote Device Study
A clinical trial, sponsored by Children's Mercy Hospital Kansas City.
- Completed
- Registry status
- 13
- Enrollment target
NCT05975658: Completed study, sponsored by Children's Mercy Hospital Kansas City.
NCT05975658 is a clinical trial that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 13 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05975658 has completed, sponsored by Children's Mercy Hospital Kansas City.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
A mixed-methods study will be used to evaluate the use of standard of care periodic pulse oximetry by parents/LAR and the feasibility of the collection of physiologic data related to the use of the Pediarity System. This system includes the Gabi Band and software platform (Gabi Analytics).
Primary Outcome
Rigorously explore the parental experience of utilizing a continuous pediatric wireless device for monitoring at home pulse oximetry compared with standard of care periodic pulse oximetry through parent interviews.
Interventions
- DEVICE Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics]
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2023-09-30 |
| Est. Completion | 2024-12-03 |
What the finished NCT05975658 record still lists
NCT05975658 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 13 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics] is the first listed.
NCT05975658 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05975658 about?
NCT05975658 is a clinical study titled "WIReD: Wireless Interstage Remote Device Study". A mixed-methods study will be used to evaluate the use of standard of care periodic pulse oximetry by parents/LAR and the feasibility of the collection of physiologic data related to the use of the Pediarity System. This system includes the Gabi Band and software platform (Gabi Analytics).
What is the current status of trial NCT05975658?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2023-09-30. Estimated completion is 2024-12-03.
What interventions are being tested in trial NCT05975658?
The interventions under investigation include: Gabi SmartCare Pediarity System [Gabi Band, Gabi Monitor App, Gabi Analytics] (DEVICE).
Who is sponsoring clinical trial NCT05975658?
This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI